Home RxNorm 2099309 moxetumomab pasudotox-tdfk 1 MG Injection Drug identity information. FDA.report links public drug records from RxNav, DailyMed, FDA NDC, Drugs@FDA, and related public sources where available. This page is informational only and is not medical, prescribing, or regulatory advice.
RxCUI 2099309
RxNorm name moxetumomab pasudotox-tdfk 1 MG Injection
Display name moxetumomab pasudotox-tdfk 1 MG Injection
Full name moxetumomab pasudotox-tdfk 1 MG Injection
Term type PSN
Status DailyMed mapping
Updated 2026-06-04 23:39:08 Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 761104 Lumoxiti moxetumomab pasudotox-tdfk 351(a) Disc 2026-07-01
RxNav Current And Historical NDCs# RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.
No records found.
UNII Substances# UNII substance links page 1 of 1 · 0 matching rows.
No records found.
DailyMed RxNorm Mappings# unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.
Set ID, RxNorm mappings, Terms table Set ID RxNorm mappings Terms SPL version Label Effective 8ddffb08-aab1-41f5-bbc6-09457e4e80ca moxetumomab pasudotox-tdfk 1 MG Injection [PSN] · moxetumomab pasudotox-tdfk 1 MG Injection [SCD] 2 2 These highlights do not include all the information needed to use LUMOXITI safely and effectively. See full prescribing information for LUMOXITI. LUMOXITI ® (moxetumomab pasudotox-tdfk) for injection, for intravenous use Initial U.S. Approval: 2018 20200903